SUSMED,Inc. Company Description

SUSMED,Inc. develops and sells therapeutic applications and platform systems in Japan.

It operates through DTx product business, and DTx platform business segments. The company develops smartphone-based therapeutic apps for diseases, such as insomnia, breast cancer, and kidney disease.

It also develops and provides clinical trial systems with blockchain technology. In addition, the company offers medical data analysis and consulting services.

The company was incorporated in 2015 and is headquartered in Tokyo, Japan.

SUSMED,Inc.

Country	Japan
Founded	2015
Industry	Biotechnology
Sector	Healthcare
Employees	50
CEO	Taro Ueno

Contact Details

Address: Nihombashi Honcho M-SQUARE Tokyo, 103-0023 Japan
Phone	86 3 6366 7780
Website	susmed.co.jp

Stock Details

Ticker Symbol	4263
Exchange	Tokyo Stock Exchange
Fiscal Year	July - June
Reporting Currency	JPY
ISIN Number	JP3319150003
SIC Code	7372

Key Executives

Name	Position
Taro Ueno	Chief Executive Officer